http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2424798

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 791
issn 1389-2010
issueIdentifier 7
pageRange 779-791
publicationName Current Pharmaceutical Biotechnology
startingPage 779
bibliographicCitation Singh S, Tice C. Structure based design of 11β-HSD1 inhibitors. Curr Pharm Biotechnol. 2010 Nov;11(7):779–91. doi: 10.2174/138920110792927748. PMID: 20809895.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b8a55e0bbb2a11aa3b930c2bd5d0780
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b15a99c501837a6d5b9a2ec8ddaa317b
date 2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/20809895
https://doi.org/10.2174/138920110792927748
isPartOf https://portal.issn.org/resource/ISSN/1389-2010
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22464
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Structure Based Design of 11β-HSD1 Inhibitors
discusses http://id.nlm.nih.gov/mesh/M0337947
http://id.nlm.nih.gov/mesh/M0007520
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015195
http://id.nlm.nih.gov/mesh/D043205Q000037
http://id.nlm.nih.gov/mesh/D004791Q000737
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002986Q000379
http://id.nlm.nih.gov/mesh/D013329
http://id.nlm.nih.gov/mesh/D024821Q000188
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D024821Q000201
http://id.nlm.nih.gov/mesh/D018360Q000379
http://id.nlm.nih.gov/mesh/D004791Q000627
http://id.nlm.nih.gov/mesh/D043205Q000378
http://id.nlm.nih.gov/mesh/D004791Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10708

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128344927

Total number of triples: 37.